Quaker Chemical (KWR) Financials

$108.71 -0.53 (-0.49%)

Closing price 05/30/2025 03:59 PM Eastern

Extended Trading

$108.48 -0.23 (-0.22%)

As of 05/30/2025 04:21 PM Eastern

Annual Income Statements for Quaker Chemical

This table shows Quaker Chemical's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	117	113	-16	121	40	32	59	20	61	51	56
Consolidated Net Income / (Loss)	117	113	-16	121	40	32	60	22	63	53	58
Net Income / (Loss) Continuing Operations	117	113	-16	121	40	32	60	22	63	53	58
Total Pre-Tax Income	155	153	7.12	147	27	29	83	61	84	70	78
Total Operating Income	195	214	52	150	59	46	88	63	85	75	77
Total Gross Profit	686	706	613	595	513	392	312	291	280	278	273
Total Revenue	1,840	1,953	1,944	1,761	1,418	1,134	868	820	747	738	766
Operating Revenue	1,840	1,953	1,944	1,761	1,418	1,134	868	820	747	738	766
Total Cost of Revenue	1,154	1,248	1,331	1,167	904	741	555	529	467	460	493
Operating Cost of Revenue	1,154	1,248	1,331	1,167	904	741	555	529	467	460	493
Total Operating Expenses	491	491	560	444	454	346	225	229	195	203	196
Selling, General & Admin Expense	485	484	464	419	381	284	208	199	194	196	196
Impairment Charge	0.00	0.00	93	0.00	38	0.00	0.00	-	-	-	-
Restructuring Charge	6.53	7.59	3.16	25	35	62	17	30	1.09	6.79	0.00
Total Other Income / (Expense), net	-40	-61	-45	-3.48	-32	-17	-4.68	-2.08	-1.34	-4.34	0.94
Interest Expense	41	51	33	22	27	17	4.04	1.36	2.89	2.59	2.37
Other Income / (Expense), net	1.35	-11	-13	19	-5.62	-0.25	-0.64	-0.72	-0.49	-3.38	0.77
Income Tax Expense	49	56	25	35	-5.30	2.08	25	42	23	18	24
Other Gains / (Losses), net	11	15	1.97	9.38	7.35	5.06	1.76	3.29	2.26	0.26	3.54
Net Income / (Loss) Attributable to Noncontrolling Interest	0.09	0.12	0.09	0.06	0.13	0.26	0.34	2.02	1.64	1.53	1.81
Basic Earnings per Share	$6.51	$6.27	($0.89)	$6.79	$2.23	$2.08	$4.46	$1.53	$4.64	$3.84	$4.27
Weighted Average Basic Shares Outstanding	17.67M	17.99M	17.95M	17.90M	17.85M	17.73M	13.34M	13.31M	13.28M	13.21M	13.30M
Diluted Earnings per Share	$6.51	$6.26	($0.89)	$6.77	$2.22	$2.08	$4.45	$1.52	$4.63	$3.84	$4.26
Weighted Average Diluted Shares Outstanding	17.67M	17.99M	17.95M	17.90M	17.85M	17.73M	13.34M	13.31M	13.28M	13.21M	13.30M
Weighted Average Basic & Diluted Shares Outstanding	17.67M	17.99M	17.95M	17.90M	17.85M	17.73M	13.34M	13.31M	13.28M	13.21M	13.30M
Cash Dividends to Common per Share	$1.88	$1.78	$1.70	$1.62	$1.56	$1.53	$1.47	$1.41	$1.36	$1.26	$1.15

This table shows Quaker Chemical's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	13	14	32	35	35	20	34	29	30	-76	26
Consolidated Net Income / (Loss)	13	14	32	35	35	20	34	29	30	-76	26
Net Income / (Loss) Continuing Operations	13	14	32	35	35	20	34	29	30	-76	26
Total Pre-Tax Income	17	19	42	48	46	34	44	40	34	-68	36
Total Operating Income	28	29	52	58	56	48	60	57	50	-54	45
Total Gross Profit	161	156	173	176	182	171	183	178	173	156	161
Total Revenue	443	444	462	464	470	467	491	495	500	485	492
Operating Revenue	443	444	462	464	470	467	491	495	500	485	492
Total Cost of Revenue	282	288	290	288	288	296	307	318	327	329	331
Operating Cost of Revenue	282	288	290	288	288	296	307	318	327	329	331
Total Operating Expenses	134	127	121	117	126	123	124	121	124	210	116
Selling, General & Admin Expense	119	125	118	117	124	121	123	120	120	121	115
Restructuring Charge	15	1.74	2.61	0.32	1.86	1.55	1.02	1.04	3.97	-4.23	0.68
Total Other Income / (Expense), net	-10	-10	-9.56	-10	-9.74	-14	-15	-16	-15	-14	-8.30
Interest Expense	9.55	9.08	10	11	11	12	13	13	13	12	8.39
Other Income / (Expense), net	-0.71	-0.93	0.78	0.42	1.08	-2.11	-2.71	-3.61	-2.24	-2.09	0.09
Income Tax Expense	7.54	8.85	12	16	13	19	14	14	9.53	11	10
Other Gains / (Losses), net	3.09	4.03	2.39	2.57	1.98	4.67	3.28	2.76	4.63	2.61	-0.21
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.01	0.00	0.03	0.03	0.03	0.03	0.04	0.05	0.01	0.02	0.04
Basic Earnings per Share	$0.73	$0.80	$1.81	$1.94	$1.96	$1.13	$1.87	$1.63	$1.64	($4.24)	$1.44
Weighted Average Basic Shares Outstanding	17.68M	17.67M	17.79M	17.91M	17.99M	17.99M	17.98M	18.00M	17.98M	17.95M	17.93M
Diluted Earnings per Share	$0.73	$0.81	$1.81	$1.94	$1.95	$1.12	$1.87	$1.63	$1.64	($4.24)	$1.44
Weighted Average Diluted Shares Outstanding	17.68M	17.67M	17.79M	17.91M	17.99M	17.99M	17.98M	18.00M	17.98M	17.95M	17.93M
Weighted Average Basic & Diluted Shares Outstanding	17.68M	17.67M	17.79M	17.91M	17.99M	17.99M	17.98M	18.00M	17.98M	17.95M	17.93M
Cash Dividends to Common per Share	$0.49	-	$0.49	$0.46	$0.46	-	$0.46	$0.44	$0.44	-	$0.44

This table details how cash moves in and out of Quaker Chemical's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-5.65	14	16	-17	38	66	13	-39	-4.20	16	-3.76
Net Cash From Operating Activities	205	279	42	49	178	82	79	65	63	73	55
Net Cash From Continuing Operating Activities	205	279	42	49	178	129	79	26	74	73	55
Net Income / (Loss) Continuing Operations	117	113	-16	121	40	32	60	22	63	53	58
Consolidated Net Income / (Loss)	117	113	-16	121	40	32	60	22	63	53	58
Depreciation Expense	84	82	80	87	83	45	20	20	13	12	12
Amortization Expense	1.41	1.41	2.94	4.75	4.75	1.98	0.07	0.24	7.01	6.81	4.33
Non-Cash Adjustments To Reconcile Net Income	11	7.01	100	-9.62	60	27	6.04	4.62	-0.02	14	0.15
Changes in Operating Assets and Liabilities, net	-8.83	76	-125	-154	-9.18	24	-6.89	-22	-20	-12	-20
Net Cash From Investing Activities	-76	-28	-40	-49	-71	-909	-12	-15	-25	-34	-84
Net Cash From Continuing Investing Activities	-76	-28	-40	-49	-71	-909	-12	-15	-25	-34	-84
Purchase of Property, Plant & Equipment	-42	-39	-29	-21	-18	-16	-13	-11	-9.95	-11	-13
Acquisitions	-39	0.00	-13	-42	-56	-893	-0.50	-5.36	-15	-24	-74
Sale of Property, Plant & Equipment	4.68	11	1.46	15	2.70	0.10	0.87	1.58	0.19	0.14	0.20
Net Cash From Financing Activities	-123	-239	25	-13	-75	844	-47	-55	-38	-17	30
Net Cash From Continuing Financing Activities	-123	-239	25	-13	-75	844	-47	-55	-38	-17	30
Repayment of Debt	-38	-204	-695	14	-50	115	-27	-2.85	-15	-0.48	-1.37
Repurchase of Common Equity	-49	0.00	0.00	-	-1.05	0.00	0.00	-32	-5.86	-7.28	0.00
Payment of Dividends	-33	-32	-30	-29	-28	-22	-20	-19	-18	-17	-16
Issuance of Debt	0.00	0.00	750	0.00	0.00	750	0.00	0.00	0.00	6.16	59
Issuance of Common Equity	-2.38	-2.75	-0.38	0.89	3.87	1.37	0.08	-1.96	-0.81	1.05	0.80
Effect of Exchange Rate Changes	-11	0.77	-10	-3.06	6.59	1.26	-6.14	5.40	-4.09	-6.02	-4.14
Cash Interest Paid	45	55	29	19	24	20	2.42	2.77	2.48	2.22	1.89
Cash Income Taxes Paid	61	57	35	35	20	15	20	22	25	21	23

This table details how cash moves in and out of Quaker Chemical's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-2.66	-23	24	-7.18	1.22	-3.83	8.95	-0.47	8.91	42	-63
Net Cash From Operating Activities	-3.05	63	68	46	27	80	83	78	38	68	-18
Net Cash From Continuing Operating Activities	-3.05	63	68	46	27	80	83	78	38	68	-18
Net Income / (Loss) Continuing Operations	13	14	32	35	35	20	34	29	30	-76	26
Consolidated Net Income / (Loss)	13	14	32	35	35	20	34	29	30	-76	26
Depreciation Expense	21	21	21	21	21	21	21	21	20	20	20
Non-Cash Adjustments To Reconcile Net Income	13	-3.14	9.20	1.58	3.52	-0.72	-0.18	5.23	2.68	93	-2.68
Changes in Operating Assets and Liabilities, net	-49	31	4.88	-12	-33	39	29	23	-15	30	-61
Net Cash From Investing Activities	-13	-21	-23	-3.92	-29	-1.83	-8.75	-11	-6.16	-11	-5.15
Net Cash From Continuing Investing Activities	-13	-21	-23	-3.92	-29	-1.83	-8.75	-11	-6.16	-11	-5.15
Purchase of Property, Plant & Equipment	-12	-22	-8.21	-6.66	-4.46	-13	-8.75	-11	-6.16	-8.31	-5.09
Acquisitions	-3.98	-	-14	-	-25	-	-	-	0.00	-3.69	-0.04
Sale of Property, Plant & Equipment	2.90	1.88	-	2.74	0.06	11	-	-	0.00	1.40	-0.02
Net Cash From Financing Activities	11	-56	-28	-46	6.56	-88	-62	-64	-25	-22	-32
Net Cash From Continuing Financing Activities	11	-56	-28	-46	6.56	-88	-62	-64	-25	-22	-32
Repayment of Debt	21	-19	-5.27	-30	16	-78	-53	-58	-15	-14	-25
Payment of Dividends	-8.57	-8.65	-8.15	-8.19	-8.19	-8.19	-7.83	-7.82	-7.81	-7.80	-7.44
Issuance of Common Equity	-1.18	-1.75	0.86	-0.05	-1.44	-1.80	-0.24	1.40	-2.11	0.24	0.21
Effect of Exchange Rate Changes	2.85	-10	5.85	-3.70	-3.27	6.52	-4.19	-3.71	2.15	6.48	-8.37

This table presents Quaker Chemical's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	2,611	2,714	2,822	2,956	2,892	2,850	710	722	692	681	666
Total Current Assets	876	928	994	920	793	716	419	407	376	358	352
Cash & Equivalents	189	195	181	165	182	124	104	90	89	81	65
Accounts Receivable	400	445	473	431	373	376	202	208	195	188	189
Inventories, net	227	234	285	265	188	175	94	87	77	75	78
Prepaid Expenses	60	55	55	60	50	42	18	21	15	14	11
Plant, Property, & Equipment, net	230	208	199	198	204	213	84	87	86	88	86
Total Noncurrent Assets	1,505	1,579	1,629	1,838	1,895	1,921	207	229	230	235	228
Long-Term Investments	98	101	88	95	96	94	21	26	23	20	22
Goodwill	519	513	515	631	631	607	83	86	81	79	78
Intangible Assets	827	897	943	1,028	1,081	1,122	64	72	73	73	70
Noncurrent Deferred & Refundable Income Taxes	9.22	11	11	16	17	15	6.95	15	24	30	24
Other Noncurrent Operating Assets	51	57	72	68	70	83	32	30	29	32	34
Total Liabilities & Shareholders' Equity	2,611	2,714	2,822	2,956	2,892	2,850	710	722	692	681	666
Total Liabilities	1,256	1,329	1,543	1,568	1,571	1,608	273	313	279	299	300
Total Current Liabilities	380	368	355	430	383	360	151	155	127	125	125
Short-Term Debt	38	23	19	57	39	38	0.67	5.74	0.71	0.66	0.40
Accounts Payable	198	185	194	227	192	164	88	93	78	67	75
Accrued Expenses	50	55	40	38	43	46	26	-	-	-	-
Dividends Payable	8.57	8.19	7.81	7.43	7.05	6.83	4.94	4.72	4.58	4.25	3.99
Current Employee Benefit Liabilities	2.33	2.21	1.56	1.55	1.47	3.41	1.21	24	19	20	21
Other Current Liabilities	83	94	92	100	100	102	31	27	24	32	24
Total Noncurrent Liabilities	877	962	1,188	1,137	1,188	1,248	122	158	114	175	175
Long-Term Debt	670	731	934	836	849	882	36	61	66	81	75
Capital Lease Obligations	20	23	27	-	27	31	0.00	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	139	147	160	179	193	211	10	9.65	12	10	8.58
Noncurrent Employee Benefit Liabilities	24	29	29	46	64	57	32	36	0.00	41	46
Other Noncurrent Operating Liabilities	24	32	39	76	55	66	44	51	36	43	45
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,354	1,385	1,279	1,388	1,321	1,242	436	410	413	381	365
Total Preferred & Common Equity	1,354	1,384	1,278	1,387	1,320	1,241	435	408	403	373	357
Total Common Equity	1,354	1,384	1,278	1,387	1,320	1,241	435	408	403	373	357
Common Stock	921	958	946	935	923	906	111	107	126	120	112
Retained Earnings	634	551	470	516	424	413	405	366	364	327	300
Accumulated Other Comprehensive Income / (Loss)	-202	-124	-138	-64	-27	-78	-81	-65	-87	-73	-54
Noncontrolling Interest	0.62	0.60	0.67	0.63	0.55	1.60	1.32	1.95	9.85	8.20	7.66

This table presents Quaker Chemical's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,664	2,736	2,672	2,714	2,733	2,790	2,858	2,832
Total Current Assets	912	942	919	933	966	984	1,029	985
Cash & Equivalents	186	212	189	196	198	189	190	139
Accounts Receivable	419	423	424	440	446	454	483	462
Inventories, net	246	245	239	240	251	275	293	317
Prepaid Expenses	61	62	67	57	71	65	63	67
Plant, Property, & Equipment, net	232	216	201	202	196	205	203	188
Plant, Property & Equipment, gross	496	474	448	445	432	442	439	426
Accumulated Depreciation	264	259	247	243	235	237	236	237
Total Noncurrent Assets	1,520	1,578	1,552	1,579	1,570	1,602	1,626	1,658
Long-Term Investments	101	103	96	100	93	92	91	77
Goodwill	525	533	518	523	504	507	517	591
Intangible Assets	830	875	866	886	890	918	936	916
Noncurrent Deferred & Refundable Income Taxes	9.44	12	13	10	9.57	10	10	11
Other Noncurrent Operating Assets	54	55	60	60	72	74	71	64
Total Liabilities & Shareholders' Equity	2,664	2,736	2,672	2,714	2,733	2,790	2,858	2,832
Total Liabilities	1,278	1,289	1,277	1,323	1,391	1,454	1,542	1,552
Total Current Liabilities	373	371	350	350	352	347	369	366
Short-Term Debt	37	39	32	28	19	19	19	20
Accounts Payable	199	192	185	191	190	194	217	209
Accrued Expenses	29	39	32	28	44	35	27	33
Dividends Payable	8.58	8.66	8.16	8.19	8.19	7.83	7.82	7.80
Current Employee Benefit Liabilities	2.23	2.18	2.19	2.21	1.57	1.58	1.57	1.54
Other Current Liabilities	97	91	90	93	89	89	97	94
Total Noncurrent Liabilities	905	918	927	972	1,039	1,107	1,172	1,186
Long-Term Debt	699	701	704	740	805	864	922	931
Capital Lease Obligations	21	21	22	23	-	-	-	26
Noncurrent Deferred & Payable Income Tax Liabilities	137	143	147	151	152	156	158	151
Noncurrent Employee Benefit Liabilities	24	26	28	29	27	29	29	38
Other Noncurrent Operating Liabilities	25	28	26	30	55	58	64	40
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Total Equity & Noncontrolling Interests	1,387	1,446	1,396	1,392	1,341	1,337	1,317	1,280
Total Preferred & Common Equity	1,386	1,446	1,395	1,391	1,340	1,336	1,316	1,279
Total Common Equity	1,386	1,446	1,395	1,391	1,340	1,336	1,316	1,279
Common Stock	923	946	956	961	956	953	948	943
Retained Earnings	638	628	604	578	539	513	492	554
Accumulated Other Comprehensive Income / (Loss)	-176	-128	-166	-147	-155	-130	-123	-218
Noncontrolling Interest	0.62	0.61	0.59	0.56	0.72	0.69	0.68	0.63

This table displays calculated financial ratios and metrics derived from Quaker Chemical's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.82%	0.50%	10.36%	24.23%	25.07%	30.66%	5.78%	9.83%	1.24%	-3.70%	5.00%
EBITDA Growth	-1.96%	133.31%	-52.76%	83.87%	52.81%	-56.63%	403.48%	-21.25%	15.52%	-4.60%	4.65%
EBIT Growth	-3.81%	413.45%	-76.55%	215.06%	17.14%	-73.67%	180.98%	-26.91%	19.20%	-8.87%	4.50%
NOPAT Growth	-2.80%	204.42%	-214.08%	61.68%	65.73%	-30.19%	423.62%	-68.16%	10.90%	2.93%	5.66%
Net Income Growth	3.42%	812.49%	-113.05%	205.20%	24.79%	-46.69%	336.42%	-64.63%	19.61%	-9.59%	-0.94%
EPS Growth	3.99%	803.37%	-113.15%	204.96%	6.73%	-53.26%	385.53%	-67.17%	20.57%	-9.86%	-0.23%
Operating Cash Flow Growth	-26.68%	567.61%	-14.59%	-72.57%	116.56%	4.56%	21.64%	3.16%	-14.51%	34.27%	-25.90%
Free Cash Flow Firm Growth	-21.22%	360.27%	-291.82%	-41.92%	107.23%	-344.68%	-1,048.18%	297.70%	-65.57%	288.07%	-153.50%
Invested Capital Growth	-3.81%	-6.14%	-1.54%	3.19%	-0.93%	181.45%	-7.18%	-11.15%	12.36%	2.18%	28.53%
Revenue Q/Q Growth	-1.24%	-0.90%	1.98%	3.60%	-0.38%	18.85%	0.09%	2.48%	1.08%	-1.44%	1.29%
EBITDA Q/Q Growth	-5.90%	55.59%	-41.72%	-7.31%	27.40%	23.57%	272.20%	-2.89%	-46.27%	-3.41%	0.73%
EBIT Q/Q Growth	-8.43%	99.85%	-68.41%	-11.15%	137.20%	0.78%	210.72%	-4.50%	-63.46%	-4.61%	-0.12%
NOPAT Q/Q Growth	-4.94%	1,697.25%	-223.87%	-10.37%	125.57%	60.79%	93.91%	-59.23%	6.80%	3.19%	-0.38%
Net Income Q/Q Growth	-4.92%	575.80%	-120.25%	-20.01%	503.56%	30.40%	81.01%	-55.04%	10.69%	-2.00%	-2.92%
EPS Q/Q Growth	-4.55%	595.56%	-120.41%	-20.17%	1,133.33%	4.52%	83.44%	-57.18%	11.03%	-2.78%	-2.29%
Operating Cash Flow Q/Q Growth	-7.46%	4.29%	107.61%	-28.93%	12.23%	30.01%	5.24%	27.99%	-16.95%	8.84%	-8.68%
Free Cash Flow Firm Q/Q Growth	66.77%	48.21%	-182.39%	214.28%	726.06%	16.54%	-990.85%	162.77%	-96.61%	62.28%	-44.55%
Invested Capital Q/Q Growth	-5.07%	-0.41%	-2.56%	-1.76%	3.92%	6.05%	188.47%	-6.47%	11.94%	-0.68%	4.11%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.29%	36.13%	31.52%	33.76%	36.22%	34.59%	72.00%	35.54%	37.51%	37.66%	35.67%
EBITDA Margin	15.31%	14.70%	6.33%	14.80%	10.00%	8.18%	24.65%	10.03%	13.99%	12.26%	12.37%
Operating Margin	10.58%	10.98%	2.69%	8.54%	4.19%	4.07%	20.24%	7.65%	11.43%	10.11%	10.10%
EBIT Margin	10.66%	10.43%	2.04%	9.61%	3.79%	4.05%	20.09%	7.56%	11.37%	9.65%	10.20%
Profit (Net Income) Margin	6.35%	5.78%	-0.82%	6.90%	2.81%	2.81%	13.79%	2.72%	8.44%	7.15%	7.61%
Tax Burden Percent	75.28%	73.71%	-222.56%	82.61%	146.60%	110.31%	143.95%	36.76%	75.04%	75.05%	74.46%
Interest Burden Percent	79.09%	75.13%	17.93%	86.81%	50.50%	63.00%	190.73%	97.81%	99.00%	98.65%	100.22%
Effective Tax Rate	31.79%	36.30%	350.17%	23.77%	-19.51%	7.21%	60.29%	68.66%	27.65%	25.32%	30.07%
Return on Invested Capital (ROIC)	7.22%	7.06%	-6.50%	5.74%	3.59%	3.18%	17.08%	5.06%	15.88%	15.37%	16.98%
ROIC Less NNEP Spread (ROIC-NNEP)	3.80%	3.12%	10.43%	6.79%	-0.90%	-0.62%	38.91%	-6.60%	0.03%	42.68%	5.42%
Return on Net Nonoperating Assets (RNNOA)	1.30%	1.42%	5.31%	3.22%	-0.49%	-0.21%	-5.88%	0.36%	0.00%	-1.25%	-0.55%
Return on Equity (ROE)	8.52%	8.48%	-1.19%	8.97%	3.10%	2.97%	28.28%	5.42%	15.88%	14.12%	16.43%
Cash Return on Invested Capital (CROIC)	11.10%	13.39%	-4.95%	2.60%	4.53%	-91.95%	-153.49%	16.87%	4.24%	13.21%	-7.99%
Operating Return on Assets (OROA)	7.36%	7.36%	1.37%	5.79%	1.87%	2.58%	24.34%	8.77%	12.36%	10.58%	12.50%
Return on Assets (ROA)	4.38%	4.08%	-0.55%	4.15%	1.39%	1.79%	16.71%	3.15%	9.18%	7.83%	9.33%
Return on Common Equity (ROCE)	8.52%	8.47%	-1.19%	8.96%	3.10%	2.97%	28.17%	5.35%	15.52%	13.82%	16.04%
Return on Equity Simple (ROE_SIMPLE)	8.62%	8.15%	-1.24%	8.75%	3.01%	2.57%	13.75%	5.47%	15.65%	14.13%	16.31%
Net Operating Profit after Tax (NOPAT)	133	137	-131	115	71	43	61	20	62	56	54
NOPAT Margin	7.22%	6.99%	-6.73%	6.51%	5.00%	3.78%	14.14%	2.40%	8.27%	7.55%	7.06%
Net Nonoperating Expense Percent (NNEP)	3.43%	3.93%	-16.93%	-1.05%	4.50%	3.81%	-2.36%	11.66%	15.85%	-27.31%	11.56%
Return On Investment Capital (ROIC_SIMPLE)	6.38%	6.32%	-5.79%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	62.71%	63.87%	68.48%	66.24%	63.78%	65.41%	128.00%	64.46%	62.49%	62.34%	64.33%
SG&A Expenses to Revenue	26.35%	24.76%	23.88%	23.78%	26.86%	25.04%	47.92%	24.24%	25.94%	26.63%	25.57%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.71%	25.14%	28.83%	25.22%	32.03%	30.52%	51.76%	27.89%	26.08%	27.55%	25.57%
Earnings before Interest and Taxes (EBIT)	196	204	40	169	54	46	174	62	85	71	78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	282	287	123	261	142	93	214	82	104	90	95
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.84	2.74	2.29	2.90	3.31	2.25	5.17	4.63	3.93	2.52	3.08
Price to Tangible Book Value (P/TBV)	329.33	0.00	0.00	0.00	0.00	0.00	7.81	7.55	6.35	4.26	5.27
Price to Revenue (P/Rev)	1.36	1.94	1.50	2.28	3.08	2.47	2.59	2.30	2.12	1.28	1.44
Price to Earnings (P/E)	21.39	33.58	0.00	33.10	110.11	88.36	37.85	93.12	25.75	18.38	19.50
Dividend Yield	1.32%	0.84%	1.03%	0.71%	0.63%	0.96%	1.71%	0.99%	1.40%	1.75%	1.33%
Earnings Yield	4.68%	2.98%	0.00%	3.02%	0.91%	1.13%	2.64%	1.07%	3.88%	5.44%	5.13%
Enterprise Value to Invested Capital (EV/IC)	1.63	2.28	1.82	2.29	2.55	1.78	6.14	5.04	3.76	2.54	3.06
Enterprise Value to Revenue (EV/Rev)	1.60	2.19	1.87	2.64	3.53	3.11	2.49	2.25	2.07	1.26	1.43
Enterprise Value to EBITDA (EV/EBITDA)	10.43	14.86	29.52	17.85	35.31	38.06	20.23	22.39	14.80	10.28	11.59
Enterprise Value to EBIT (EV/EBIT)	14.97	20.94	91.56	27.47	93.13	76.95	24.83	29.69	18.22	13.06	14.06
Enterprise Value to NOPAT (EV/NOPAT)	22.11	31.24	0.00	40.55	70.55	82.48	35.28	93.64	25.03	16.70	20.30
Enterprise Value to Operating Cash Flow (EV/OCF)	14.35	15.30	86.96	95.05	28.06	42.86	27.46	28.43	24.63	12.66	20.08
Enterprise Value to Free Cash Flow (EV/FCFF)	14.38	16.47	0.00	89.59	55.99	0.00	0.00	28.09	93.80	19.42	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.54	0.56	0.77	0.64	0.69	0.77	0.17	0.16	0.16	0.22	0.21
Long-Term Debt to Equity	0.51	0.54	0.75	0.60	0.66	0.74	0.16	0.15	0.16	0.21	0.21
Financial Leverage	0.34	0.45	0.51	0.47	0.54	0.34	-0.30	-0.06	-0.02	-0.03	-0.10
Leverage Ratio	1.94	2.08	2.17	2.16	2.24	2.12	3.39	1.72	1.73	1.80	1.76
Compound Leverage Factor	1.54	1.56	0.39	1.87	1.13	1.34	3.23	1.68	1.71	1.78	1.76
Debt to Total Capital	34.94%	35.94%	43.38%	39.16%	40.93%	43.38%	15.48%	14.02%	13.88%	17.72%	17.18%
Short-Term Debt to Total Capital	1.80%	1.08%	0.85%	2.50%	1.74%	1.75%	0.28%	1.20%	0.15%	0.14%	0.09%
Long-Term Debt to Total Capital	33.13%	34.86%	42.53%	36.66%	39.18%	41.64%	15.20%	12.82%	13.73%	17.58%	17.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.03%	0.03%	0.03%	0.02%	0.07%	0.56%	0.41%	2.06%	1.77%	1.74%
Common Equity to Total Capital	65.03%	64.03%	56.59%	60.81%	59.05%	56.54%	183.96%	85.57%	84.07%	80.51%	81.08%
Debt to EBITDA	2.58	2.71	7.96	3.43	6.46	10.26	0.34	0.81	0.64	0.91	0.80
Net Debt to EBITDA	1.56	1.68	5.77	2.43	4.50	7.92	-0.83	-0.59	-0.43	-0.21	-0.11
Long-Term Debt to EBITDA	2.45	2.62	7.80	3.21	6.18	9.85	0.34	0.74	0.63	0.90	0.80
Debt to NOPAT	5.48	5.69	-7.49	7.79	12.90	22.24	0.60	3.40	1.08	1.47	1.40
Net Debt to NOPAT	3.32	3.52	-5.43	5.52	8.99	17.16	-2.90	-2.48	-0.73	-0.35	-0.20
Long-Term Debt to NOPAT	5.19	5.52	-7.34	7.29	12.35	21.34	1.17	3.11	1.07	1.46	1.39
Altman Z-Score	2.71	3.21	2.38	2.77	2.59	1.85	7.82	6.17	6.05	4.40	4.78
Noncontrolling Interest Sharing Ratio	0.04%	0.05%	0.05%	0.04%	0.08%	0.17%	0.39%	1.43%	2.27%	2.12%	2.33%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.31	2.52	2.80	2.14	2.07	1.99	2.76	2.63	2.95	2.88	2.81
Quick Ratio	1.55	1.74	1.84	1.38	1.45	1.39	2.02	1.93	2.23	2.16	2.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	204	259	-100	52	89	-1,236	-278	66	16	48	-25
Operating Cash Flow to CapEx	551.16%	1,010.17%	154.36%	728.93%	1,173.69%	533.44%	655.40%	696.74%	642.68%	673.81%	425.57%
Free Cash Flow to Firm to Interest Expense	4.98	5.11	-3.06	2.33	3.36	-72.82	-68.79	48.27	5.71	18.52	-10.74
Operating Cash Flow to Interest Expense	4.99	5.50	1.28	2.19	6.71	4.85	19.49	47.69	21.73	28.41	23.07
Operating Cash Flow Less CapEx to Interest Expense	4.08	4.96	0.45	1.89	6.13	3.94	16.52	40.84	18.35	24.19	17.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.71	0.67	0.60	0.49	0.64	2.42	1.16	1.09	1.10	1.23
Accounts Receivable Turnover	4.35	4.26	4.30	4.38	3.79	3.92	8.45	4.06	3.89	3.90	4.31
Inventory Turnover	5.00	4.81	4.85	5.16	4.99	5.51	12.25	6.43	6.13	6.02	6.60
Fixed Asset Turnover	8.41	9.61	9.81	8.78	6.79	7.62	20.34	9.51	8.61	8.51	8.94
Accounts Payable Turnover	6.03	6.59	6.33	5.58	5.08	5.89	12.28	6.20	6.44	6.46	6.69
Days Sales Outstanding (DSO)	83.83	85.75	84.84	83.28	96.41	93.08	172.71	89.81	93.74	93.48	84.62
Days Inventory Outstanding (DIO)	72.98	75.87	75.33	70.76	73.21	66.23	119.20	56.73	59.53	60.65	55.29
Days Payable Outstanding (DPO)	60.58	55.41	57.68	65.47	71.84	62.01	120.50	58.90	56.67	56.47	54.55
Cash Conversion Cycle (CCC)	96.23	106.22	102.50	88.57	97.79	97.29	173.03	87.64	96.60	97.66	85.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,803	1,874	1,997	2,028	1,965	1,984	705	366	411	366	358
Invested Capital Turnover	1.00	1.01	0.97	0.88	0.72	0.84	4.85	2.11	1.92	2.04	2.40
Increase / (Decrease) in Invested Capital	-71	-123	-31	63	-18	1,279	679	-46	45	7.82	80
Enterprise Value (EV)	2,936	4,268	3,635	4,651	5,005	3,531	2,164	1,841	1,546	930	1,098
Market Capitalization	2,495	3,786	2,923	4,017	4,367	2,794	4,613	1,888	1,581	941	1,101
Book Value per Share	$76.10	$76.97	$71.27	$77.53	$74.05	$69.97	$32.63	$30.65	$30.38	$28.04	$26.94
Tangible Book Value per Share	$0.43	($1.39)	($10.04)	($15.18)	($22.00)	($27.53)	$21.61	$18.80	$18.77	$16.58	$15.76
Total Capital	2,081	2,162	2,258	2,281	2,236	2,194	946	476	479	463	441
Total Debt	727	777	980	893	915	952	73	67	66	82	76
Total Long-Term Debt	690	754	961	836	876	914	72	61	66	81	75
Net Debt	440	481	711	633	637	735	-178	-49	-45	-19	-11
Capital Expenditures (CapEx)	37	28	27	6.71	15	15	24	9.30	9.77	11	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	345	389	478	382	267	271	327	168	161	153	162
Debt-free Net Working Capital (DFNWC)	534	584	659	547	449	394	535	258	250	234	227
Net Working Capital (NWC)	497	560	639	490	410	356	534	252	249	234	227
Net Nonoperating Expense (NNE)	16	24	-115	-6.73	31	11	1.51	-2.63	-1.28	2.98	-4.20
Net Nonoperating Obligations (NNO)	449	490	718	640	645	742	-168	-44	-1.14	-15	-6.76
Total Depreciation and Amortization (D&A)	86	83	83	91	88	47	40	20	20	19	17
Debt-free, Cash-free Net Working Capital to Revenue	18.77%	19.93%	24.57%	21.66%	18.83%	23.89%	18.85%	20.45%	21.56%	20.76%	21.19%
Debt-free Net Working Capital to Revenue	29.04%	29.89%	33.89%	31.04%	31.65%	34.79%	30.86%	31.41%	33.45%	31.75%	29.64%
Net Working Capital to Revenue	27.00%	28.69%	32.90%	27.81%	28.90%	31.41%	30.78%	30.71%	33.36%	31.66%	29.59%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$6.51	$6.27	($0.89)	$6.79	$2.23	$2.08	$4.46	$1.53	$4.64	$3.84	$4.27
Adjusted Weighted Average Basic Shares Outstanding	17.67M	17.99M	17.95M	17.90M	17.85M	17.73M	13.34M	13.31M	13.28M	13.21M	13.30M
Adjusted Diluted Earnings per Share	$6.51	$6.26	($0.89)	$6.77	$2.22	$2.08	$4.45	$1.52	$4.63	$3.84	$4.26
Adjusted Weighted Average Diluted Shares Outstanding	17.67M	17.99M	17.95M	17.90M	17.85M	17.73M	13.34M	13.31M	13.28M	13.21M	13.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.67M	17.99M	17.95M	17.90M	17.85M	17.73M	13.34M	13.31M	13.28M	13.21M	13.30M
Normalized Net Operating Profit after Tax (NOPAT)	137	141	104	134	93	100	73	65	63	61	54
Normalized NOPAT Margin	7.46%	7.24%	5.35%	7.61%	6.55%	8.86%	16.82%	7.91%	8.38%	8.24%	7.06%
Pre Tax Income Margin	8.43%	7.84%	0.37%	8.35%	1.91%	2.55%	19.16%	7.40%	11.25%	9.52%	10.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.78	4.02	1.22	7.58	2.02	2.70	21.56	45.67	29.37	27.54	32.95
NOPAT to Interest Expense	3.24	2.70	-4.02	5.14	2.67	2.52	15.17	14.48	21.38	21.54	22.82
EBIT Less CapEx to Interest Expense	3.88	3.48	0.39	7.28	1.45	1.79	18.59	38.83	25.99	23.32	27.53
NOPAT Less CapEx to Interest Expense	2.33	2.15	-4.85	4.84	2.10	1.61	12.20	7.64	18.00	17.33	17.40
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.42%	28.04%	-190.02%	23.55%	71.16%	68.47%	67.53%	83.47%	27.96%	31.33%	28.08%
Augmented Payout Ratio	70.61%	28.04%	-190.02%	23.55%	73.80%	68.47%	67.53%	226.01%	37.25%	45.14%	28.08%

This table displays calculated financial ratios and metrics derived from Quaker Chemical's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.71%	-4.93%	-5.78%	-6.43%	-6.08%	-3.65%	-0.33%	0.62%	5.48%	8.45%	9.61%
EBITDA Growth	-38.62%	-26.33%	-4.81%	8.48%	13.87%	288.49%	20.19%	64.19%	39.85%	-167.69%	9.49%
EBIT Growth	-52.45%	-39.14%	-7.58%	10.68%	18.70%	182.84%	27.10%	126.30%	75.35%	-284.11%	21.92%
NOPAT Growth	-61.27%	-29.37%	-10.57%	5.08%	11.75%	158.51%	28.19%	27.48%	41.36%	-283.31%	-8.53%
Net Income Growth	-63.36%	-29.85%	-3.97%	18.77%	19.35%	126.64%	30.11%	104.53%	49.04%	-518.97%	-16.62%
EPS Growth	-62.56%	-27.68%	-3.21%	19.02%	18.90%	126.42%	29.86%	103.75%	47.75%	-519.80%	-16.76%
Operating Cash Flow Growth	-111.20%	-20.73%	-18.50%	-40.84%	-27.93%	16.85%	566.75%	3,785.03%	699.81%	46.66%	-247.97%
Free Cash Flow Firm Growth	-64.42%	-39.87%	-90.63%	-30.00%	-13.49%	2,410.13%	340.39%	789.51%	303.97%	85.22%	134.21%
Invested Capital Growth	-1.61%	-3.81%	0.92%	-3.57%	-4.50%	-6.14%	-8.16%	-5.72%	-5.43%	-1.54%	-0.74%
Revenue Q/Q Growth	-0.26%	-3.93%	-0.28%	-1.32%	0.57%	-4.79%	-0.98%	-0.94%	3.16%	-1.51%	-0.03%
EBITDA Q/Q Growth	-3.81%	-33.27%	-7.93%	3.40%	15.98%	-13.79%	4.92%	8.54%	291.98%	-154.97%	43.33%
EBIT Q/Q Growth	-4.16%	-46.51%	-10.82%	4.00%	22.69%	-18.78%	6.80%	11.53%	185.62%	-224.62%	90.15%
NOPAT Q/Q Growth	0.79%	-57.85%	-6.35%	-2.66%	83.80%	-46.63%	10.05%	3.53%	196.23%	-216.93%	9.44%
Net Income Q/Q Growth	-8.96%	-56.17%	-7.27%	-0.99%	74.30%	-39.99%	14.69%	-0.50%	138.90%	-393.12%	80.28%
EPS Q/Q Growth	-9.88%	-55.25%	-6.70%	-0.51%	74.11%	-40.11%	14.72%	-0.61%	138.68%	-394.44%	80.00%
Operating Cash Flow Q/Q Growth	-104.84%	-7.23%	46.82%	70.04%	-65.77%	-4.61%	6.56%	107.16%	-44.51%	481.01%	-741.34%
Free Cash Flow Firm Q/Q Growth	-46.87%	345.04%	-82.06%	-16.13%	-10.19%	-30.67%	34.04%	3.66%	2,498.08%	-113.22%	170.74%
Invested Capital Q/Q Growth	3.43%	-5.07%	1.20%	-0.98%	1.12%	-0.41%	-3.30%	-1.93%	-0.61%	-2.56%	-0.73%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.41%	35.17%	37.33%	37.91%	38.65%	36.64%	37.37%	35.87%	34.68%	32.23%	32.66%
EBITDA Margin	10.73%	11.12%	16.01%	17.35%	16.55%	14.35%	15.85%	14.96%	13.65%	-7.34%	13.15%
Operating Margin	6.24%	6.53%	11.19%	12.61%	11.82%	10.33%	12.13%	11.46%	9.98%	-11.06%	9.06%
EBIT Margin	6.08%	6.32%	11.36%	12.70%	12.05%	9.88%	11.58%	10.74%	9.54%	-11.49%	9.08%
Profit (Net Income) Margin	2.92%	3.20%	7.00%	7.53%	7.51%	4.33%	6.87%	5.93%	5.91%	-15.66%	5.26%
Tax Burden Percent	74.36%	74.66%	76.79%	72.55%	77.01%	59.17%	76.57%	72.63%	85.76%	111.60%	71.36%
Interest Burden Percent	64.54%	67.68%	80.29%	81.73%	80.88%	74.09%	77.50%	76.08%	72.23%	122.17%	81.23%
Effective Tax Rate	43.42%	46.55%	28.86%	32.79%	27.32%	54.50%	30.88%	34.18%	27.67%	0.00%	28.05%
Return on Invested Capital (ROIC)	3.40%	3.49%	7.84%	8.38%	8.51%	4.74%	8.41%	7.42%	6.97%	-7.48%	6.04%
ROIC Less NNEP Spread (ROIC-NNEP)	2.85%	3.21%	6.95%	7.58%	7.64%	4.46%	7.27%	6.23%	6.01%	-13.13%	5.19%
Return on Net Nonoperating Assets (RNNOA)	1.01%	1.10%	2.48%	3.03%	3.31%	2.02%	3.64%	3.14%	3.04%	-6.69%	2.83%
Return on Equity (ROE)	4.41%	4.59%	10.32%	11.41%	11.82%	6.76%	12.05%	10.56%	10.00%	-14.17%	8.87%
Cash Return on Invested Capital (CROIC)	7.39%	11.10%	6.47%	11.16%	11.91%	13.39%	8.90%	5.79%	3.43%	-4.95%	5.88%
Operating Return on Assets (OROA)	4.10%	4.37%	7.74%	8.79%	8.32%	6.97%	8.20%	7.35%	6.41%	-7.73%	5.99%
Return on Assets (ROA)	1.97%	2.21%	4.77%	5.21%	5.18%	3.06%	4.87%	4.06%	3.97%	-10.54%	3.48%
Return on Common Equity (ROCE)	4.41%	4.59%	10.32%	11.40%	11.82%	6.76%	12.04%	10.56%	10.00%	-14.16%	8.86%
Return on Equity Simple (ROE_SIMPLE)	6.81%	0.00%	8.49%	8.90%	8.52%	0.00%	1.25%	0.67%	-0.47%	0.00%	6.12%
Net Operating Profit after Tax (NOPAT)	16	16	37	39	40	22	41	37	36	-38	32
NOPAT Margin	3.53%	3.49%	7.96%	8.47%	8.59%	4.70%	8.39%	7.55%	7.22%	-7.74%	6.52%
Net Nonoperating Expense Percent (NNEP)	0.55%	0.28%	0.89%	0.80%	0.87%	0.29%	1.13%	1.19%	0.96%	5.65%	0.85%
Return On Investment Capital (ROIC_SIMPLE)	0.73%	0.75%	-	-	-	1.02%	-	-	-	-1.66%	-
Cost of Revenue to Revenue	63.59%	64.83%	62.67%	62.09%	61.35%	63.36%	62.63%	64.14%	65.32%	67.77%	67.34%
SG&A Expenses to Revenue	26.88%	28.25%	25.57%	25.23%	26.43%	25.98%	25.03%	24.19%	23.90%	24.98%	23.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.17%	28.64%	26.14%	25.30%	26.83%	26.31%	25.24%	24.40%	24.70%	43.29%	23.60%
Earnings before Interest and Taxes (EBIT)	27	28	53	59	57	46	57	53	48	-56	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	48	49	74	80	78	67	78	74	68	-36	65
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.57	1.84	2.08	2.18	2.64	2.74	2.12	2.59	2.66	2.29	1.98
Price to Tangible Book Value (P/TBV)	70.25	329.33	78.50	270.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.20	1.36	1.62	1.61	1.91	1.94	1.44	1.75	1.78	1.50	1.33
Price to Earnings (P/E)	23.05	21.39	24.53	24.56	31.03	33.58	171.28	393.78	0.00	0.00	32.47
Dividend Yield	1.53%	1.32%	1.08%	1.06%	0.87%	0.84%	1.10%	0.89%	0.87%	1.03%	1.17%
Earnings Yield	4.34%	4.68%	4.08%	4.07%	3.22%	2.98%	0.58%	0.25%	0.00%	0.00%	3.08%
Enterprise Value to Invested Capital (EV/IC)	1.42	1.63	1.82	1.88	2.20	2.28	1.79	2.09	2.10	1.82	1.61
Enterprise Value to Revenue (EV/Rev)	1.46	1.60	1.85	1.86	2.17	2.19	1.71	2.06	2.11	1.87	1.73
Enterprise Value to EBITDA (EV/EBITDA)	10.57	10.43	11.54	11.62	14.06	14.86	18.29	23.69	29.20	29.52	15.62
Enterprise Value to EBIT (EV/EBIT)	15.90	14.97	16.13	16.11	19.61	20.94	33.10	45.22	69.16	91.56	26.26
Enterprise Value to NOPAT (EV/NOPAT)	24.39	22.11	24.73	24.48	29.43	31.24	444.03	0.00	0.00	0.00	31.24
Enterprise Value to Operating Cash Flow (EV/OCF)	15.17	14.35	15.63	14.88	15.54	15.30	12.62	24.44	48.47	86.96	163.92
Enterprise Value to Free Cash Flow (EV/FCFF)	19.03	14.38	28.22	16.50	18.05	16.47	19.30	35.00	59.47	0.00	27.30
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.55	0.54	0.53	0.54	0.57	0.56	0.61	0.66	0.71	0.77	0.76
Long-Term Debt to Equity	0.52	0.51	0.50	0.52	0.55	0.54	0.60	0.65	0.70	0.75	0.75
Financial Leverage	0.35	0.34	0.36	0.40	0.43	0.45	0.50	0.50	0.51	0.51	0.54
Leverage Ratio	1.94	1.94	1.96	2.00	2.06	2.08	2.12	2.16	2.16	2.17	2.17
Compound Leverage Factor	1.25	1.32	1.58	1.63	1.66	1.54	1.65	1.64	1.56	2.65	1.76
Debt to Total Capital	35.32%	34.94%	34.45%	35.19%	36.24%	35.94%	38.06%	39.79%	41.68%	43.38%	43.31%
Short-Term Debt to Total Capital	1.74%	1.80%	1.76%	1.51%	1.27%	1.08%	0.89%	0.87%	0.86%	0.85%	0.91%
Long-Term Debt to Total Capital	33.58%	33.13%	32.69%	33.68%	34.97%	34.86%	37.18%	38.92%	40.82%	42.53%	42.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Common Equity to Total Capital	64.65%	65.03%	65.52%	64.78%	63.74%	64.03%	61.90%	60.18%	58.29%	56.59%	56.66%
Debt to EBITDA	3.03	2.58	2.54	2.50	2.67	2.71	4.46	5.15	6.60	7.96	4.63
Net Debt to EBITDA	1.88	1.56	1.49	1.56	1.67	1.68	2.89	3.51	4.63	5.77	3.61
Long-Term Debt to EBITDA	2.88	2.45	2.41	2.39	2.57	2.62	4.36	5.04	6.46	7.80	4.53
Debt to NOPAT	6.98	5.48	5.44	5.27	5.58	5.69	108.42	-445.47	-21.44	-7.49	9.26
Net Debt to NOPAT	4.33	3.32	3.18	3.29	3.50	3.52	70.10	-303.57	-15.05	-5.43	7.21
Long-Term Debt to NOPAT	6.64	5.19	5.16	5.04	5.39	5.52	105.89	-435.70	-21.00	-7.34	9.06
Altman Z-Score	2.31	2.50	2.72	2.78	3.00	3.02	2.56	2.73	2.62	2.27	2.24
Noncontrolling Interest Sharing Ratio	0.04%	0.04%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.45	2.31	2.54	2.63	2.66	2.52	2.74	2.84	2.79	2.80	2.69
Quick Ratio	1.62	1.55	1.71	1.75	1.82	1.74	1.83	1.86	1.82	1.84	1.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	46	87	20	109	130	144	208	155	150	-6.25	47
Operating Cash Flow to CapEx	-32.35%	306.45%	827.71%	1,179.99%	618.61%	4,354.68%	952.80%	719.46%	613.24%	985.20%	-349.57%
Free Cash Flow to Firm to Interest Expense	4.84	9.57	1.89	10.12	11.99	12.09	16.31	12.22	11.33	-0.51	5.64
Operating Cash Flow to Interest Expense	-0.32	6.95	6.57	4.31	2.52	6.66	6.53	6.15	2.85	5.51	-2.13
Operating Cash Flow Less CapEx to Interest Expense	-1.31	4.68	5.78	3.94	2.11	6.50	5.84	5.30	2.39	4.95	-2.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.67	0.69	0.68	0.69	0.69	0.71	0.71	0.68	0.67	0.67	0.66
Accounts Receivable Turnover	4.22	4.35	4.29	4.31	4.17	4.26	4.34	4.29	4.19	4.30	4.26
Inventory Turnover	4.71	5.00	4.69	4.59	4.53	4.81	4.51	4.43	4.48	4.85	4.58
Fixed Asset Turnover	8.34	8.41	9.04	9.33	9.49	9.61	10.24	9.93	9.84	9.81	10.05
Accounts Payable Turnover	5.87	6.03	6.08	6.22	5.93	6.59	6.41	5.93	5.65	6.33	6.11
Days Sales Outstanding (DSO)	86.44	83.83	85.16	84.75	87.58	85.75	84.11	85.08	87.21	84.84	85.76
Days Inventory Outstanding (DIO)	77.41	72.98	77.88	79.56	80.59	75.87	80.96	82.32	81.44	75.33	79.66
Days Payable Outstanding (DPO)	62.14	60.58	59.99	58.68	61.55	55.41	56.94	61.58	64.59	57.68	59.73
Cash Conversion Cycle (CCC)	101.72	96.23	103.05	105.63	106.62	106.22	108.13	105.82	104.06	102.50	105.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,865	1,803	1,899	1,877	1,895	1,874	1,882	1,946	1,985	1,997	2,049
Invested Capital Turnover	0.96	1.00	0.99	0.99	0.99	1.01	1.00	0.98	0.96	0.97	0.93
Increase / (Decrease) in Invested Capital	-31	-71	17	-70	-89	-123	-167	-118	-114	-31	-15
Enterprise Value (EV)	2,644	2,936	3,454	3,519	4,171	4,268	3,376	4,064	4,163	3,635	3,300
Market Capitalization	2,174	2,495	3,009	3,046	3,675	3,786	2,842	3,461	3,502	2,923	2,537
Book Value per Share	$78.42	$76.10	$80.71	$77.54	$77.33	$76.97	$74.48	$74.30	$73.32	$71.27	$71.34
Tangible Book Value per Share	$1.75	$0.43	$2.14	$0.63	($0.97)	($1.39)	($3.03)	($4.98)	($7.66)	($10.04)	($12.72)
Total Capital	2,144	2,081	2,206	2,153	2,183	2,162	2,165	2,220	2,258	2,258	2,257
Total Debt	757	727	760	758	791	777	824	883	941	980	978
Total Long-Term Debt	720	690	721	725	763	754	805	864	922	961	957
Net Debt	470	440	445	473	495	481	533	602	660	711	762
Capital Expenditures (CapEx)	9.43	21	8.21	3.92	4.40	1.83	8.75	11	6.16	6.91	5.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	391	345	397	413	415	389	435	467	489	478	501
Debt-free Net Working Capital (DFNWC)	577	534	609	601	611	584	633	657	679	659	639
Net Working Capital (NWC)	540	497	571	569	583	560	614	637	660	639	619
Net Nonoperating Expense (NNE)	2.71	1.32	4.42	4.37	5.10	1.73	7.43	7.99	6.57	38	6.19
Net Nonoperating Obligations (NNO)	478	449	453	481	504	490	541	610	668	718	770
Total Depreciation and Amortization (D&A)	21	21	22	22	21	21	21	21	21	20	20
Debt-free, Cash-free Net Working Capital to Revenue	21.55%	18.77%	21.32%	21.83%	21.57%	19.93%	22.07%	23.70%	24.85%	24.57%	26.26%
Debt-free Net Working Capital to Revenue	31.82%	29.04%	32.71%	31.81%	31.75%	29.89%	32.14%	33.30%	34.49%	33.89%	33.55%
Net Working Capital to Revenue	29.77%	27.00%	30.63%	30.09%	30.31%	28.69%	31.16%	32.32%	33.50%	32.90%	32.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.73	$0.80	$1.81	$1.94	$1.96	$1.13	$1.87	$1.63	$1.64	($4.24)	$1.44
Adjusted Weighted Average Basic Shares Outstanding	17.68M	17.67M	17.79M	17.91M	17.99M	17.99M	17.98M	18.00M	17.98M	17.95M	17.93M
Adjusted Diluted Earnings per Share	$0.73	$0.81	$1.81	$1.94	$1.95	$1.12	$1.87	$1.63	$1.64	($4.24)	$1.44
Adjusted Weighted Average Diluted Shares Outstanding	17.68M	17.67M	17.79M	17.91M	17.99M	17.99M	17.98M	18.00M	17.98M	17.95M	17.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.68M	17.67M	17.79M	17.91M	17.99M	17.99M	17.98M	18.00M	17.98M	17.95M	17.93M
Normalized Net Operating Profit after Tax (NOPAT)	24	16	39	39	42	35	42	38	39	-40	33
Normalized NOPAT Margin	5.39%	3.70%	8.36%	8.52%	8.88%	7.46%	8.53%	7.68%	7.79%	-8.35%	6.62%
Pre Tax Income Margin	3.92%	4.28%	9.12%	10.38%	9.75%	7.32%	8.97%	8.17%	6.89%	-14.04%	7.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.82	3.09	5.07	5.47	5.23	3.86	4.44	4.18	3.60	-4.51	5.33
NOPAT to Interest Expense	1.64	1.71	3.56	3.65	3.73	1.84	3.22	2.94	2.73	-3.04	3.83
EBIT Less CapEx to Interest Expense	1.83	0.83	4.28	5.11	4.82	3.71	3.76	3.33	3.14	-5.07	4.72
NOPAT Less CapEx to Interest Expense	0.65	-0.56	2.76	3.29	3.32	1.68	2.53	2.08	2.26	-3.60	3.22
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	35.55%	28.42%	26.65%	26.10%	27.01%	28.04%	187.16%	346.88%	-497.94%	-190.02%	38.00%
Augmented Payout Ratio	35.55%	70.61%	26.65%	26.10%	27.01%	28.04%	187.16%	346.88%	-497.94%	-190.02%	38.00%

Frequently Asked Questions About Quaker Chemical's Financials

When does Quaker Chemical's financial year end?

According to the most recent income statement we have on file, Quaker Chemical's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Quaker Chemical's net income changed over the last 10 years?

Quaker Chemical's net income appears to be on an upward trend, with a most recent value of $116.73 million in 2024, rising from $58.30 million in 2014. The previous period was $112.87 million in 2023. See where experts think Quaker Chemical is headed by visiting Quaker Chemical's forecast page.

What is Quaker Chemical's operating income?

Quaker Chemical's total operating income in 2024 was $194.71 million, based on the following breakdown:

Total Gross Profit: $686.03 million
Total Operating Expenses: $491.32 million

How has Quaker Chemical revenue changed over the last 10 years?

Over the last 10 years, Quaker Chemical's total revenue changed from $765.86 million in 2014 to $1.84 billion in 2024, a change of 140.2%.

How much debt does Quaker Chemical have?

Quaker Chemical's total liabilities were at $1.26 billion at the end of 2024, a 5.5% decrease from 2023, and a 318.3% increase since 2014.

How much cash does Quaker Chemical have?

In the past 10 years, Quaker Chemical's cash and equivalents has ranged from $64.73 million in 2014 to $194.53 million in 2023, and is currently $188.88 million as of their latest financial filing in 2024.

How has Quaker Chemical's book value per share changed over the last 10 years?

Over the last 10 years, Quaker Chemical's book value per share changed from 26.94 in 2014 to 76.10 in 2024, a change of 182.5%.

Related Companies

This page (NYSE:KWR) was last updated on 5/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quaker Chemical (KWR) Financials

Frequently Asked Questions About Quaker Chemical's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quaker Chemical (KWR) Financials

Annual Income Statements for Quaker Chemical

Quarterly Income Statements for Quaker Chemical

Annual Cash Flow Statements for Quaker Chemical

Quarterly Cash Flow Statements for Quaker Chemical

Annual Balance Sheets for Quaker Chemical

Quarterly Balance Sheets for Quaker Chemical

Annual Metrics And Ratios for Quaker Chemical

Quarterly Metrics And Ratios for Quaker Chemical

Frequently Asked Questions About Quaker Chemical's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools